Abbott launches COVID-19 home test kit in India

By: |
July 12, 2021 3:33 PM

The company will deliver millions of Panbio COVID-19 rapid antigen tests, available for self-use, to ease the burden on healthcare systems in urban and rural India, Abbott said in a statement.

After Covid-19 broke out last year, India has seen a steady rise in fungal infections also.After Covid-19 broke out last year, India has seen a steady rise in fungal infections also.

Healthcare major Abbott on Monday said it has launched COVID-19 home test kit in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms at a price of Rs 325 for a single test kit pack.

The company will deliver millions of Panbio COVID-19 rapid antigen tests, available for self-use, to ease the burden on healthcare systems in urban and rural India, Abbott said in a statement. In alignment with the current ICMR advisory on self-use, these tests will be made available to ramp up testing of symptomatic and asymptomatic individuals and contacts of confirmed coronavirus cases, it added.

“Scaling access to easy, accurate, and fast testing can speed up the country’s preparedness and curb community contagion,” ICMR former Director-General Nirmal Kumar Ganguly said. Self-testing at home empowers individuals with the ability to carry out the first line of protection against disease transmission, he added.

In India, Abbott will offer self-tests for use at home, assisted professional testing at the point of care and laboratories, as well as workplace testing to help enable a sense of normalcy in returning to places of employment, the company said. “Rapid antigen testing is critical in the fight against COVID-19 and Abbott is delivering a variety of diagnostics options at a critical juncture in the pandemic,” Divisional vice president of Abbott’s rapid diagnostics business in the Asia Pacific, Sanjeev Johar said. Self-testing is a proven tool that provides an added layer of defense along with public health protocols and the vaccine rollout, he added.

“By the end of July, we plan to deliver 7 million test kits in our first phase and have the capacity to bring millions of more test kits to support the country’s needs. With an extensive global supply network and manufacturing capabilities, Abbott will also be able to scale up manufacturing as needed to meet the testing needs of India,” Abbott said.

A single-test kit pack Abbott Panbio COVID-19 antigen self-test is priced at Rs 325; pack of 4 at Rs 1,250, pack of 10 at Rs 2,800 and pack of 20 at Rs 5,400, it added “The test kits will be made available pan-India, reaching urban and rural regions of the country via both online and offline distribution channels. Our aim is to maximise availability and we aim to reach more than 80 percent of India’s population,” Abbott said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Black fungus: Patients opt for leech therapy; All you need to know
2Coronavirus lockdown and lack of sunlight: How Ayurveda helps in maintaining Vitamin D balance
3CDSCO classifies 80 IVD medical devices under new medical device rules for their effective regulation